These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21923319)

  • 21. Exemption from import/export requirements for personal medical use. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2004 Sep; 69(177):55343-7. PubMed ID: 15366181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacists correcting schedule II prescriptions: DEA flip-flops continue.
    Abood RR
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):393-6. PubMed ID: 21133749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of Controlled Substance Prescribing: An Overview for Certified Nurse-Midwives and Certified Midwives.
    Osborne K
    J Midwifery Womens Health; 2017 May; 62(3):341-347. PubMed ID: 28544336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the DEA's new "prescription series" regulation balanced?
    Gilson AM; Joranson DE
    J Pain Palliat Care Pharmacother; 2008; 22(3):218-20. PubMed ID: 19042852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pain meds in the spotlight. Senate staffers get demo of DEA regulations.
    Connole P
    Provider; 2010 Feb; 36(2):20-1. PubMed ID: 20183969
    [No Abstract]   [Full Text] [Related]  

  • 26. Placement of gamma-butyrolactone in List I of the Controlled Substances Act (21 U.S.C. 802(34)). Drug Enforcement Administration, Justice. Final rule.
    Fed Regist; 2000 Apr; 65(79):21645-7. PubMed ID: 11010670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain.
    Fishman SM; Papazian JS; Gonzalez S; Riches PS; Gilson A
    Pain Med; 2004 Sep; 5(3):309-24. PubMed ID: 15367312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Information on foreign chain of distribution for ephedrine, pseudoephedrine, and phenylpropanolamine. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2010 Mar; 75(43):10168-72. PubMed ID: 20383917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experts worry about chilling effect of federal regulations on treating pain.
    Schmidt C
    J Natl Cancer Inst; 2005 Apr; 97(8):554-5. PubMed ID: 15840873
    [No Abstract]   [Full Text] [Related]  

  • 30. From balanced pain care to drug trafficking: the case of Dr. William Hurwitz and the DEA.
    Fishman SM
    Pain Med; 2005; 6(2):162-4. PubMed ID: 15773882
    [No Abstract]   [Full Text] [Related]  

  • 31. Guidelines for prescribers of controlled substances. A joint statement of the Drug Enforcement Administration and the DEA/Practitioners Working Committee.
    J Conn State Dent Assoc; 1981 Mar; 55(1):18-9. PubMed ID: 6785326
    [No Abstract]   [Full Text] [Related]  

  • 32. DEA grants prescriber numbers to certain Massachusetts pharmacists.
    J Pain Palliat Care Pharmacother; 2011; 25(3):297-9. PubMed ID: 21998842
    [No Abstract]   [Full Text] [Related]  

  • 33. The DEA proposes schedule II substance rule.
    Buchanan BL
    WMJ; 2007 Jul; 106(4):230. PubMed ID: 17844715
    [No Abstract]   [Full Text] [Related]  

  • 34. Why is the DEA hounding this doctor?
    Roosevelt M
    Time; 2005 Jul; 166(4):56-8. PubMed ID: 16075844
    [No Abstract]   [Full Text] [Related]  

  • 35. DEA regulation of controlled substances and listed chemicals.
    Gilbert JA
    Food Drug Law J; 2010; 65(3):623-30. PubMed ID: 24479244
    [No Abstract]   [Full Text] [Related]  

  • 36. Amendment of the fee exemption for federal, state and local government employees--DEA, Justice. Final rule.
    Fed Regist; 1994 Feb; 59(37):8859. PubMed ID: 10133414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definition of "positional isomer" as it pertains to the control of schedule I controlled substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2007 Dec; 72(231):67850-2. PubMed ID: 18064769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exemption of chemical mixtures containing the List I chemicals ephedrine, N-methylephedrine, N-methylpseudoephedrine, norpseudoephedrine, phenylpropanolamine, and pseudoephedrine. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 May; 68(84):23195-206. PubMed ID: 12725239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New DEA rules expand options for controlled substance disposal.
    Peterson DM
    J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):22-6. PubMed ID: 25607591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulating mandatory medical prescription.
    Mitchell CN
    Am J Law Med; 1986; 12(2):207-39. PubMed ID: 3327377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.